|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500108616 |
|
最近更新日期: Date of Last Refreshed on: |
2025-09-02 16:08:06 |
|
注册时间: Date of Registration: |
2025-09-02 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
中孕期超声筛查质控项目 |
|
Public title: |
Quality control project for mid pregnancy ultrasound screening |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中孕期超声筛查质控项目 |
|
Scientific title: |
Quality control project for mid pregnancy ultrasound screening |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王红燕 |
研究负责人: |
王红燕 |
|
Applicant: |
Hongyan Wang |
Study leader: |
Hongyan Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 133 6602 9878 |
研究负责人电话:
Study leader's |
+86 10 6915 5493 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
whychina@126.com |
研究负责人电子邮件: Study leader's E-mail: |
whychina@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市东城区帅府园1号北京协和医院超声科 |
研究负责人通讯地址: |
王府井帅府园1号(100730) |
|
Applicant address: |
US department, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing |
Study leader's address: |
No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京协和医院 |
||
|
Applicant's institution: |
Peking Union Medical College Hospital |
||
|
研究负责人所在单位: |
北京协和医院 |
||
|
Affiliation of the Leader: |
Peking Union Medical College Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
I-24PJ0553 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医学科学院北京协和医院伦理审查委员会 |
||
|
Name of the ethic committee: |
PUMCH Institutional Review Board |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-03-13 00:00:00 | ||
|
伦理委员会联系人: |
李佳月 |
||
|
Contact Name of the ethic committee: |
Jiayue Li |
||
|
伦理委员会联系地址: |
王府井帅府园1号(100730) |
||
|
Contact Address of the ethic committee: |
No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 69156874 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
dott1994@163.com |
|
研究实施负责(组长)单位: |
中国医学科学院北京协和医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking Union Medical College Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
王府井帅府园1号(100730) |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中孕期超声筛查质控项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Quality control project for mid pregnancy ultrasound screening |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
none |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
优生优育是我国的基本国策,对提高中华民族整体素质有着重大意义。超声检查由于对胎儿无创伤、无致畸作用,安全性高,是产前筛查胎儿畸形的重要工具。然而,超声检查具有较强的操作者依赖性,产科超声筛查的切面留存是否标准、全面,报告是否合乎规范,影响着筛查结果的准确性,可能影响临床医生的决策和孕妇及胎儿的预后,影响母胎安全。因此,产科超声筛查的质量控制尤为重要。 目前,我国产科超声筛查的质量控制主要依赖专家现场抽查,由于产科超声筛查留存切面数量较多,抽查费时费力,效率较低,且抽查频率有限。利用信息化手段,提高产科超声筛查质控的效率及抽查频率,在日常工作中对超声医师及时反馈,全面提高产科超声筛查的水平,是亟需解决的问题。此外,我国目前对于各级医疗机构产科超声筛查存图规范及报告书写情况、是否符合目前国际成熟报告体系标准等,仍缺乏明确的数据。因此,通过全国范围各级医疗机构产科超声筛查数据的收集及调研,了解全国产科超声筛查总体情况,参考国际成熟报告体系标准,制定并推行适合我国人群的产科超声筛查标准化存图及结构化报告体系,制定中国专家共识,有助于实现全国范围内产科超声筛查的规范化与同质化。 |
||||||||||||||||||||||
|
Objectives of Study: |
At present, the quality control of obstetric ultrasound screening in China mainly relies on on-site spot checks by experts. Due to the large number of retained sections in obstetric ultrasound screening, spot checks are time-consuming, labor-intensive, inefficient, and the frequency of spot checks is limited. The use of information technology to improve the efficiency and sampling frequency of obstetric ultrasound screening quality control, timely feedback to ultrasound physicians in daily work, and comprehensively improve the level of obstetric ultrasound screening are urgent problems that need to be solved. In addition, there is still a lack of clear data in China regarding the storage standards and report writing of obstetric ultrasound screening in medical institutions at all levels, as well as whether they comply with the current international mature reporting system standards. Therefore, through the collection and research of obstetric ultrasound screening data from medical institutions at all levels nationwide, we can understand the overall situation of obstetric ultrasound screening nationwide, refer to international mature reporting system standards, develop and implement a standardized image and structured reporting system for obstetric ultrasound screening suitable for Chinese people, and develop a consensus among Chinese experts, which will help to achieve the standardization and homogenization of obstetric ultrasound screening nationwide. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.孕(20~24+6周)低风险单胎妊娠; 2.孕妇体质量指数(BMI)为18.0~26.0kg/m^2; 3.孕妇既往月经规律,末次月经信息准确,或人工辅助生殖胚胎移植相关信息完整; 4.孕早期胎儿头臀长与孕周核对准确; |
||||||||||||||||||||||
|
Inclusion criteria |
1.Low risk singleton pregnancy (20-24+6 weeks); |
||||||||||||||||||||||
|
排除标准: |
1.孕妇合并先兆子痫、妊娠高血压和糖尿病等; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Pregnant women with preeclampsia, pregnancy induced hypertension and diabetes; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-07-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-03-15 00:00:00 至 To 2025-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
none |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
预计共享时间:2025年9月15日 方式:通过国家卫生健康委国际交流与合作中心“超声医学质量控制平台”(www.nuqcc.cn)共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Expected sharing time: September 15, 2025 Method: Shared through the "Ultrasound Medical Quality Control Platform" (www.nuqcc. cn) of the International Exchange and Cooperation Center of the National Health Commission |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF已上传伦理审查系统。 所有试点医院上传的超声图像等数据由国家卫生健康委国际交流与合作中心“超声医学质量控制平台”保存,按照国家信息安全等级保护要求及中心信息安全相关规定进行数据安全处理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF has been uploaded to the ethics review system. All ultrasound images and other data uploaded by pilot hospitals are saved by the "Ultrasound Medical Quality Control Platform" of the International Exchange and Cooperation Center of the National Health Commission, and processed for data security in accordance with national information security level protection requirements and relevant regulations of the center. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |